651 related articles for article (PubMed ID: 19854145)
1. Benznidazole alters the pattern of Cyclophosphamide-induced reactivation in experimental Trypanosoma cruzi-dependent lineage infection.
Santos DM; Martins TA; Caldas IS; Diniz LF; Machado-Coelho GL; Carneiro CM; Oliveira Rde P; Talvani A; Lana M; Bahia MT
Acta Trop; 2010 Feb; 113(2):134-8. PubMed ID: 19854145
[TBL] [Abstract][Full Text] [Related]
2. Trypanosoma cruzi: acute and long-term infection in the vertebrate host can modify the response to benznidazole.
Caldas S; Santos FM; de Lana M; Diniz LF; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Mar; 118(3):315-23. PubMed ID: 17945216
[TBL] [Abstract][Full Text] [Related]
3. Trypanosoma cruzi: Induction of benznidazole resistance in vivo and its modulation by in vitro culturing and mice infection.
Dos Santos FM; Caldas S; de Assis Cáu SB; Crepalde GP; de Lana M; Machado-Coelho GL; Veloso VM; Bahia MT
Exp Parasitol; 2008 Dec; 120(4):385-90. PubMed ID: 18823980
[TBL] [Abstract][Full Text] [Related]
4. Trypanosoma cruzi: Genetic diversity influences the profile of immunoglobulins during experimental infection.
dos Santos DM; Talvani A; Guedes PM; Machado-Coelho GL; de Lana M; Bahia MT
Exp Parasitol; 2009 Jan; 121(1):8-14. PubMed ID: 18848935
[TBL] [Abstract][Full Text] [Related]
5. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
6. Reduction of parasite levels in blood improves pregnancy outcome during experimental Trypanosoma cruzi infection.
Solana ME; Alba Soto CD; Fernández MC; Poncini CV; Postan M; González Cappa SM
Parasitology; 2009 May; 136(6):627-39. PubMed ID: 19366478
[TBL] [Abstract][Full Text] [Related]
7. Lack of correlation between in vitro susceptibility to Benznidazole and phylogenetic diversity of Trypanosoma cruzi, the agent of Chagas disease.
Villarreal D; Barnabé C; Sereno D; Tibayrenc M
Exp Parasitol; 2004; 108(1-2):24-31. PubMed ID: 15491545
[TBL] [Abstract][Full Text] [Related]
8. Canova medication modifies parasitological parameters in mice infected with Trypanosoma cruzi.
Pupulin AR; Marques-Araujo S; Toledo MJ; Gomes ML; Takejima E; Cuman RK; Bersani-Amado CA
Exp Parasitol; 2010 Dec; 126(4):435-40. PubMed ID: 20433834
[TBL] [Abstract][Full Text] [Related]
9. Effects of specific treatment on parasitological and histopathological parameters in mice infected with different Trypanosoma cruzi clonal genotypes.
Toledo MJ; Bahia MT; Veloso VM; Carneiro CM; Machado-Coelho GL; Alves CF; Martins HR; Cruz RE; Tafuri WL; Lana M
J Antimicrob Chemother; 2004 Jun; 53(6):1045-53. PubMed ID: 15102747
[TBL] [Abstract][Full Text] [Related]
10. Trypanosoma cruzi: effect of benznidazole therapy combined with the iron chelator desferrioxamine in infected mice.
Francisco AF; de Abreu Vieira PM; Arantes JM; Pedrosa ML; Martins HR; Silva M; Veloso VM; de Lana M; Bahia MT; Tafuri WL; Carneiro CM
Exp Parasitol; 2008 Dec; 120(4):314-9. PubMed ID: 18789321
[TBL] [Abstract][Full Text] [Related]
11. Effects of dehydroepiandrosterone-sulfate (DHEA-S) and benznidazole treatments during acute infection of two different Trypanosoma cruzi strains.
Santos CD; Loria RM; Oliveira LG; Kuehn CC; Toldo MP; Albuquerque S; do Prado JC
Immunobiology; 2010 Dec; 215(12):980-6. PubMed ID: 20163889
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of essential oil of Syzygium aromaticum alone and in combination with benznidazole on murine oral infection with Trypanosoma cruzi IV.
Zanusso Junior G; Massago M; Kian D; Toledo MJO
Exp Parasitol; 2018 Feb; 185():92-97. PubMed ID: 29305891
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
[TBL] [Abstract][Full Text] [Related]
14. Persistence of PCR-positive tissue in benznidazole-treated mice with negative blood parasitological and serological tests in dual infections with Trypanosoma cruzi stocks from different genotypes.
Martins HR; Figueiredo LM; Valamiel-Silva JC; Carneiro CM; Machado-Coelho GL; Vitelli-Avelar DM; Bahia MT; Martins-Filho OA; Macedo AM; Lana M
J Antimicrob Chemother; 2008 Jun; 61(6):1319-27. PubMed ID: 18343804
[TBL] [Abstract][Full Text] [Related]
15. Trypanosoma cruzi: alteration in the lymphoid compartments following interruption of infection by early acute benznidazole therapy in mice.
Olivieri BP; de Souza AP; Cotta-de-Almeida V; de Castro SL; Araújo-Jorge T
Exp Parasitol; 2006 Nov; 114(3):228-34. PubMed ID: 16620811
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic effects of benznidazole in Swiss mice that are orally inoculated with Trypanosoma cruzi IV strains from the Western Brazilian Amazon.
Teston APM; Fernandes NS; Abegg CP; de Abreu AP; Sarto MPM; Gomes ML; Toledo MJO
Exp Parasitol; 2021 Sep; 228():108136. PubMed ID: 34280400
[TBL] [Abstract][Full Text] [Related]
17. Impact of benznidazole on infection course in mice experimentally infected with Trypanosoma cruzi I, II, and IV.
Gruendling AP; Massago M; Teston AP; Monteiro WM; Kaneshima EN; Araújo SM; Gomes ML; Barbosa Md; Toledo MJ
Am J Trop Med Hyg; 2015 Jun; 92(6):1178-89. PubMed ID: 25940197
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of novel benznidazole solutions during the experimental infection with Trypanosoma cruzi.
Manarin R; Lamas MC; Bottasso E; Serra E; Revelli S; Salomón CJ
Parasitol Int; 2013 Feb; 62(1):79-81. PubMed ID: 22975280
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma cruzi: Impact of dual-clone infections on parasite biological properties in BALB/c mice.
Martins HR; Toledo MJ; Veloso VM; Carneiro CM; Machado-Coelho GL; Tafuri WL; Bahia MT; Valadares HM; Macedo AM; Lana M
Exp Parasitol; 2006 Apr; 112(4):237-46. PubMed ID: 16406355
[TBL] [Abstract][Full Text] [Related]
20. An in vitro iron superoxide dismutase inhibitor decreases the parasitemia levels of Trypanosoma cruzi in BALB/c mouse model during acute phase.
Olmo F; Urbanová K; Rosales MJ; Martín-Escolano R; Sánchez-Moreno M; Marín C
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):110-6. PubMed ID: 26236582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
